Stomach Cancer Trial, Recruiting NCT07243015 Sponsor: City of Hope Medical Center Condition: Stomach Cancer
Back to Stomach Cancer

Stomach Cancer Trial, Recruiting

NCT07243015
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with stomach cancer (specifically a type called gastric adenocarcinoma), confirmed through laboratory testing of tissue samples
  • People who have had surgery with the goal of fully removing the cancer (meaning no cancer was left behind at the edges of the removed tissue)
  • People for whom blood plasma samples taken both before and after surgery are available
  • People who have documented medical records showing whether their cancer came back or spread after surgery
  • People who have signed a written agreement to participate in the trial

Who may not be able to join:

  • People whose blood plasma samples do not contain enough volume or sufficient quality to allow the required laboratory analysis
  • People who have, or have had, another separate cancer at the same time or at a different time
  • People who received chemotherapy before surgery but do not have any recorded medical follow-up after surgery
  • People who have not given consent to participate, or whose medical records are incomplete

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 9 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 626-218-3452

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
15 January 2025
Est. completion
18 June 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Recurrence-Free Survival (RFS)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov